Let’s ChatTune in to hear how EKTA’s most recent research sparked a journey to discovering a breakthrough drug target that has been shown to help shrink skin tumors when it is blocked by pharmaceutically engineered molecules that block the protein known as AQUAPORIN 3 (AQP3) ! --- Send in a voice message: https://podcasters.spotify.com/pod/show/skincareanarchy/messageSupport this podcast: https://podcasters.spotify.com/pod/show/skincareanarchy/supportSupport the Show.Follow The Show On All Socials Using The Tag @skincareanarchy Hosted on Acast. See acast.com/privacy for more information.
No persons identified in this episode.
This episode hasn't been transcribed yet
Help us prioritize this episode for transcription by upvoting it.
Popular episodes get transcribed faster
Other recent transcribed episodes
Transcribed and ready to explore now
Before the Crisis: How You and Your Relatives Can Prepare for Financial Caregiving
06 Dec 2025
Motley Fool Money
OpenAI's Code Red, Sacks vs New York Times, New Poverty Line?
06 Dec 2025
All-In with Chamath, Jason, Sacks & Friedberg
OpenAI's Code Red, Sacks vs New York Times, New Poverty Line?
06 Dec 2025
All-In with Chamath, Jason, Sacks & Friedberg
Anthropic Finds AI Answers with Interviewer
05 Dec 2025
The Daily AI Show
#2423 - John Cena
05 Dec 2025
The Joe Rogan Experience
Warehouse to wellness: Bob Mauch on modern pharmaceutical distribution
05 Dec 2025
McKinsey on Healthcare